Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

107.14 -1.47 (-1.35%)

Streaming Delayed Price Updated: 12:20 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

52 53 Next >

ABBOTT LABORATORIES (NYSE:ABT) – A Quality Stock Worth Considering ↗

June 12, 2025

ABBOTT LABORATORIES (NYSE:ABT) meets key quality investing criteria with strong revenue growth, high ROIC, and solid financial health, making it a stock worth considering for long-term portfolios.

Via Chartmill

5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

June 11, 2025

Steady growth and dividend increases over decades can make investors remarkably wealthy.

Via The Motley Fool

Topics Economy

Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued ↗

June 10, 2025

The agreement is to develop and commercialize integrated diabetes solutions that combine Abbott's future dual glucose-ketone sensor with San Diego, California- based Tandem's innovative insulin...

Via Stocktwits

3 Low-Volatility Stocks in Hot Water

June 10, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Peering Into Abbott Laboratories's Recent Short Interest ↗

June 09, 2025

Via Benzinga

1 Mooning Stock with Exciting Potential and 2 to Think Twice About

June 09, 2025

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

ABBOTT LABORATORIES (NYSE:ABT) - A Strong Technical Setup for Breakout Investors ↗

June 03, 2025

ABBOTT LABORATORIES (NYSE:ABT) shows strong technicals and a high-quality setup, making it a potential breakout candidate for traders.

Via Chartmill

3 Stocks With 3% to 9% Yields Just Raised Dividends Again

June 02, 2025

Via MarketBeat

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges ↗

June 02, 2025

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.

Via Benzinga

How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott ↗

May 28, 2025

The company said the regulatory path forward for one of its key systems is too murky to pursue.

Via Investor's Business Daily

2 Dividend Stocks to Buy With $500 and Hold Forever ↗

May 23, 2025

Via The Motley Fool

ABBOTT LABORATORIES (NYSE:ABT) – A Quality Stock Worth Considering ↗

May 22, 2025

ABBOTT LABORATORIES (NYSE:ABT) meets key quality investing criteria with strong revenue growth, high ROIC, and excellent profit quality, making it a solid long-term candidate.

Via Chartmill

3 Magnificent Stocks That Are Passive Income Machines ↗

May 17, 2025

Via The Motley Fool

What's going on in today's session: S&P500 movers ↗

May 15, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.

Via Chartmill

$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)

May 13, 2025

Via Get News

Topics Death Economy

Recent Filing Shows That Rep. Bruce Westerman Sold Over $137K Worth of Apple Stock ↗

May 13, 2025

Via Benzinga

ABBOTT LABORATORIES (NYSE:ABT) - A Strong Technical Setup for Breakout Investors ↗

May 13, 2025

ABBOTT LABORATORIES (NYSE:ABT) shows strong technicals and a high-quality breakout setup, supported by institutional interest and clear support/resistance levels.

Via Chartmill

Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Abbott Laboratories (NYSE:ABT)

May 07, 2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Abbott Laboratories...

Via StockStory

1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar

May 06, 2025

"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their...

Via StockStory

Jensen Huang, Magic Johnson, Patrick Dempsey, Linda Yaccarino And More Bigwigs Headline Milken Global Conference 2025: What You Need To Know ↗

May 05, 2025

The Milken Institute's 28th annual Global Conference, featuring prominent figures like Jensen Huang, Magic Johnson, and Linda Yaccarino, is focusing on key global issues such as AI, healthcare, and...

Via Benzinga

Topics Artificial Intelligence

Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now ↗

May 05, 2025

Via The Motley Fool

Topics Government Stocks World Trade

2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio? ↗

May 03, 2025

Via The Motley Fool

If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again? ↗

May 01, 2025

Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?

Via Investor's Business Daily

Topics Animal Testing Economy Government

Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential ↗

May 01, 2025

Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential

Via Chartmill

A Look Into Abbott Laboratories Inc's Price Over Earnings ↗

April 28, 2025

Via Benzinga

3 Dividend Stocks to Buy and Hold for the Next Decade ↗

April 28, 2025

Via The Motley Fool

If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy

April 25, 2025

AbbVie is well-positioned for industry-leading growth, as Skyrizi and Rinvoq sales outperform, driving system-wide growth alongside a diversified portfolio.

Via MarketBeat

What To Expect From Penumbra’s (PEN) Q1 Earnings

April 22, 2025

Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

April 22, 2025

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

What To Expect From Boston Scientific’s (BSX) Q1 Earnings

April 22, 2025

Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to look for.

Via StockStory

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.